Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

FENC - Fennec Pharmaceuticals Inc. Financial... | Finranks

Home

/

FENC

F

Fennec Pharmaceuticals Inc. (FENC)

NCM – Real Time Price. Currency in USD

11.94

-0.84 (-6.57%)

Market open: Aug 12, 2026, 11:26 AM EDT

12.40

-0.38 (-2.95%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

45M

48M

21M

2M

Cost of goods sold

-4M

-3M

-1M

-86K

Gross Profit

41M

44M

20M

1M

Operating expenses (excl. COGS)

-47M

-42M

-33M

-24M

Operating Income

-6M

3M

-13M

-23M

Non-operating income, total

-3M

-3M

-3M

-1M

Pretax income

-10M

-71K

-16M

-24M

Equity in earnings

0

0

0

0

Taxes

-106K

-365K

0

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-10M

-436K

-16M

-24M

Discontinued operations

0

0

0

0

Net income

-10M

-436K

-16M

-24M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

71M+57.0%

45M+67.3%

27M-0.3%

27M

Total current assets

67M

44M

27M

27M

Total non-current assets

4M

822K

6K

211K

Total liabilities

35M-30.9%

51M+32.0%

38M+30.4%

30M

Total current liabilities

11M

7M

8M

5M

Total non-current liabilities

25M

44M

31M

25M

Total equity

35M

-6M

-12M

-3M

Total liabilities & shareholders' equities

71M

45M

27M

27M

Total debt

0-100.0%

18M-39.2%

30M+20.7%

25M

Name

2025

2024

2023

2022

Cash from operating activities

-14M

27M

-17M

-18M

Cash from investing activities

0

0

0

0

Cash from financing activities

25M

-14M

7M

21M

Free cash flow

-14M-153.5%

27M+257.4%

-17M+5.1%

-18M